56 related articles for article (PubMed ID: 10441474)
1. Characterization of residues in human IgE and IgG binding site by chemical modification of ovomucoid third domain.
Zhang JW; Mine Y
Biochem Biophys Res Commun; 1999 Aug; 261(3):610-3. PubMed ID: 10441474
[TBL] [Abstract][Full Text] [Related]
2. Characterization of IgE and IgG epitopes on ovomucoid using egg-white-allergic patients' sera.
Zhang JW; Mine Y
Biochem Biophys Res Commun; 1998 Dec; 253(1):124-7. PubMed ID: 9875231
[TBL] [Abstract][Full Text] [Related]
3. Identification and fine mapping of IgG and IgE epitopes in ovomucoid.
Mine Y; Wei Zhang J
Biochem Biophys Res Commun; 2002 Apr; 292(4):1070-4. PubMed ID: 11944924
[TBL] [Abstract][Full Text] [Related]
4. NMR determination of pKa values for Asp, Glu, His, and Lys mutants at each variable contiguous enzyme-inhibitor contact position of the turkey ovomucoid third domain.
Song J; Laskowski M; Qasim MA; Markley JL
Biochemistry; 2003 Mar; 42(10):2847-56. PubMed ID: 12627950
[TBL] [Abstract][Full Text] [Related]
5. IgE binding properties of the recombinant ovomucoid third domain expressed in Escherichia coli.
Sasaki E; Mine Y
Biochem Biophys Res Commun; 2001 Apr; 282(4):947-51. PubMed ID: 11352643
[TBL] [Abstract][Full Text] [Related]
6. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
Rupa P; Mine Y
Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
[TBL] [Abstract][Full Text] [Related]
7. Binding residues and catalytic domain of soluble Saccharomyces cerevisiae processing alpha-glucosidase I.
Faridmoayer A; Scaman CH
Glycobiology; 2005 Dec; 15(12):1341-8. PubMed ID: 16014748
[TBL] [Abstract][Full Text] [Related]
8. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
Song J; Laskowski M; Qasim MA; Markley JL
Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
[TBL] [Abstract][Full Text] [Related]
9. Genetic attachment of undecane peptides to ovomucoid third domain can suppress the production of specific IgG and IgE antibodies.
Mine Y; Rupa P
Biochem Biophys Res Commun; 2003 Nov; 311(1):223-8. PubMed ID: 14575717
[TBL] [Abstract][Full Text] [Related]
10. Genetically glycosylated ovomucoid third domain can modulate Immunoglobulin E antibody production and cytokine response in BALB/c mice.
Rupa P; Nakamura S; Mine Y
Clin Exp Allergy; 2007 Jun; 37(6):918-28. PubMed ID: 17517106
[TBL] [Abstract][Full Text] [Related]
11. The determinants of carboxyl pKa values in turkey ovomucoid third domain.
Li H; Robertson AD; Jensen JH
Proteins; 2004 May; 55(3):689-704. PubMed ID: 15103631
[TBL] [Abstract][Full Text] [Related]
12. Engineered recombinant ovomucoid third domain can desensitize Balb/c mice of egg allergy.
Rupa P; Mine Y
Allergy; 2006 Jul; 61(7):836-42. PubMed ID: 16792581
[TBL] [Abstract][Full Text] [Related]
13. The effects of chemical modification on the antigenicity of human and rabbit immunoglobulin G.
Hunneyball IM; Stanworth DR
Immunology; 1976 Jun; 30(6):881-94. PubMed ID: 68918
[TBL] [Abstract][Full Text] [Related]
14. Effects of unfolding treatment assisted glycation on the IgE/IgG binding capacity and antioxidant activity of ovomucoid.
Xia X; Li J; Liang R; Li Y; Ma X; Yang Y; Lozano-Ojalvo D
Food Funct; 2024 Jan; 15(1):196-207. PubMed ID: 38047408
[TBL] [Abstract][Full Text] [Related]
15. IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site.
Sandomenico A; Monti SM; Marasco D; Dathan N; Palumbo R; Saviano M; Ruvo M
Mol Immunol; 2009 Oct; 46(16):3300-9. PubMed ID: 19699527
[TBL] [Abstract][Full Text] [Related]
16. Effect of lysine side chain length on intra-helical glutamate--lysine ion pairing interactions.
Cheng RP; Girinath P; Ahmad R
Biochemistry; 2007 Sep; 46(37):10528-37. PubMed ID: 17718542
[TBL] [Abstract][Full Text] [Related]
17. Predicting DNA-binding amino acid residues from electrostatic stabilization upon mutation to Asp/Glu and evolutionary conservation.
Chen YC; Wu CY; Lim C
Proteins; 2007 May; 67(3):671-80. PubMed ID: 17340633
[TBL] [Abstract][Full Text] [Related]
18. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
[TBL] [Abstract][Full Text] [Related]
19. Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy.
Järvinen KM; Beyer K; Vila L; Bardina L; Mishoe M; Sampson HA
Allergy; 2007 Jul; 62(7):758-65. PubMed ID: 17573723
[TBL] [Abstract][Full Text] [Related]
20. Control of lysine reactivity in four-helix bundle proteins by site-selective pKa depression: expanding the versatility of proteins by postsynthetic functionalization.
Andersson LK; Caspersson M; Baltzer L
Chemistry; 2002 Aug; 8(16):3687-97. PubMed ID: 12203296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
